First, we were able to validate the prognostic value of CD300A‐CD300LF expression within the TCGA cohorts (Figure 3B) and cytogenetically normal (CN) subsets of AML (Figure 3C). This evidence concerns the gene CD300LF and acute myeloid leukemia.